Paradigm Biocapital Advisors LP

Q4 2021 13F Holdings Report, Stock Holdings

Signature - Title: David K. Kim - Chief Operating Officer and Chief Compliance Officer
Location: New York, NY
Holdings as of: December 31, 2021
Value $: $350M
Num holdings: 24
Date filed: 2/14/2022, 09:40 AM
Form type: 13F-HR
Description: All US holdings of this investor are reported in this report. Top holdings included MRTX, ASND, ZNTL, VRDN, and ARNA.
Next filing: Q1 2022 - May 16, 2022
SEC: View on sec.gov

Sym	Weight	Trade Impact	Company	Class	Shares Change	Activity	Value Change $	Value $	* Price $	Shares	Principal
Loading...

Showing 0 to 0 of 0 entries

Compare Q4 2021 to

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name	Title	City, State	Date
David K. Kim	Chief Operating Officer and Chief Compliance Officer	New York, New York	2/14/2022